207 related articles for article (PubMed ID: 26197769)
1. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.
Yamazaki H; Todo Y; Okamoto K; Yamashiro K; Kato H
J Gynecol Oncol; 2015 Oct; 26(4):255-61. PubMed ID: 26197769
[TBL] [Abstract][Full Text] [Related]
2. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
3. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
[TBL] [Abstract][Full Text] [Related]
4. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
6. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
9. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
Balaya V; Bresset A; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngo C; Mathevet P; Lécuru F;
Int J Gynecol Cancer; 2020 Sep; 30(9):1317-1325. PubMed ID: 32753560
[TBL] [Abstract][Full Text] [Related]
11. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
Kim M; Suh DH; Kim K; Lee HJ; Kim YB; No JH
Int J Gynecol Cancer; 2017 Feb; 27(2):332-338. PubMed ID: 28114236
[TBL] [Abstract][Full Text] [Related]
13. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
[TBL] [Abstract][Full Text] [Related]
14. Preoperative MRI criteria for trials on less radical surgery in Stage IB1 cervical cancer.
Lee JY; Youm J; Kim TH; Cho JY; Kim MA; Suh DH; Lim MC; Kim JW; Park NH; Song YS
Gynecol Oncol; 2014 Jul; 134(1):47-51. PubMed ID: 24768849
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
[TBL] [Abstract][Full Text] [Related]
16. [Parametrial involvement in cervical cancer IB1 patients treated with radical hysterectomy in Peru].
Urrutia C; Santos C; Zevallos A; López A; Montoya A; Sánchez M; Valdivia H; Velarde C; Mantilla R; Esperanza M; Castañeda C; Zaharia M; Álvarez M
Rev Peru Med Exp Salud Publica; 2014; 31(3):431-6. PubMed ID: 25418639
[TBL] [Abstract][Full Text] [Related]
17. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
18. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
19. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
[TBL] [Abstract][Full Text] [Related]
20. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]